How many 8-K filings has Xbiotech Inc. filed?

Xbiotech Inc. (XBIT) has 9 8-K (Current Event Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Xbiotech Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Xbiotech Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Xbiotech Inc. (XBIT) — 8-K Filings

All 8-K filings from Xbiotech Inc.. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

XBiotech Inc. Announces Director Changes and Officer Compensation — Dec 9, 2025 Risk: medium
XBiotech Inc. announced on December 5, 2025, the departure of Director Dr. George J. V. Johnson and the election of new Director Dr. David M. R. Johnson. The co
XBiotech Reports Material Agreement, Officer/Director Changes — Oct 3, 2025 Risk: medium
XBiotech Inc. filed an 8-K on October 3, 2025, reporting on events that occurred on October 1, 2025. The filing indicates an entry into a material definitive ag
XBiotech Inc. Files 8-K on Shareholder Vote Matters — Sep 2, 2025 Risk: low
XBiotech Inc. filed an 8-K on September 2, 2025, reporting on matters submitted to a vote of security holders as of August 29, 2025. The filing details the comp
XBiotech Inc. Reports Board and Executive Compensation Changes — Jun 24, 2025 Risk: medium
XBiotech Inc. announced on June 24, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of a di
XBiotech Inc. Faces Delisting Notice — Apr 7, 2025 Risk: high
XBiotech Inc. filed an 8-K on April 7, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective April 1, 2025
XBiotech Inc. Reports Director and Officer Changes — Apr 1, 2025 Risk: medium
XBiotech Inc. filed an 8-K on March 27, 2025, reporting changes in its board of directors and certain officers, as well as updates to compensatory arrangements.
XBiotech Inc. Reports Director/Officer Changes & Compensation — Dec 31, 2024 Risk: medium
XBiotech Inc. filed an 8-K on December 31, 2024, reporting changes related to its board of directors and officers, including the departure of certain individual
XBiotech Inc. Files 8-K on Security Holder Votes — Jun 20, 2024 Risk: low
XBiotech Inc. filed an 8-K on June 20, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate struct
XBiotech Reports Material Agreement, New Debt, Unregistered Equity Sales — Jan 4, 2024
XBiotech Inc. (XBIT) filed an 8-K on January 4, 2024, reporting events from January 3, 2024, including entering into a material definitive agreement, creating a

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX